Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-213424
Filing Date
2026-05-08
Accepted
2026-05-08 08:30:42
Documents
74
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ck0002104204-20260331.htm   iXBRL 10-Q 2891712
2 EX-31.1 ck0002104204-ex31_1.htm EX-31.1 16715
3 EX-31.2 ck0002104204-ex31_2.htm EX-31.2 16736
4 EX-32.1 ck0002104204-ex32_1.htm EX-32.1 11005
5 EX-32.2 ck0002104204-ex32_2.htm EX-32.2 11042
  Complete submission text file 0001193125-26-213424.txt   9896449

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ck0002104204-20260331.xsd EX-101.SCH 1240845
78 EXTRACTED XBRL INSTANCE DOCUMENT ck0002104204-20260331_htm.xml XML 1619761
Mailing Address 47071 BAYSIDE PARKWAY FREMONT CA 94538
Business Address 47071 BAYSIDE PARKWAY FREMONT CA 94538 510-626-9888
Alamar Biosciences, Inc. (Filer) CIK: 0002104204 (see all company filings)

EIN.: 364899036 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-43235 | Film No.: 26956197
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)